Episode 81

EP 81: Cracking the druggable genome with Dietrich Stephan, Founder and CEO of NeuBase Therapeutics

Download Subscribe Transcript
00:00:00
/
00:42:38
RSS Feed Transcript Download (97.6 MB) Link with Timestamp

June 29th, 2022

42 mins 38 secs

Transcript

Link with Timestamp

Download MP3 (97.6 MB)

Your Host

About this Episode

This week Patrick is joined by Dietrich Stephan, Founder and CEO of NeuBase Therapeutics. They discuss how to overcome the challenges of ’un-druggable’ diseases, how Neubase is cracking the druggable genome using its scalable technology, and how biotech companies are innovating to secure the investment needed to accelerate precision medicine during a challenging period for the industry.